Stratmont Indus. (530495)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I start with a simple question: what kind of business am I buying? Stratmont is in trading and distribution. That alone makes me cautious, because distributors usually have thin margins and little pricing power; their moat is often just a contract or relationship that can vanish. The numbers confirm the risk. At ₹40.47, the market cap is ₹121 Cr, but the trailing P/E is 70.77 and the price-to-book is 3.83 against a book value of ₹10.56. That is not a classic Benjamin Graham bargain. ROCE is only 7.15%, so the company is not earning a spectacular return on capital. ROE of 12.39% is decent, but not enough to justify such a premium. Still, the recent figures force me to look deeper. Sales grew 89.82% and profits are reported up 1000%, though from a very low base. The latest quarter had sales of ₹42 Cr and net profit of ₹2 Cr, a net margin of roughly 4.8%. If that level of earnings is sustainable, the forward valuation becomes more reasonable. The Piotroski score of 7/9 is encouraging, and the PEG of 0.13 suggests the market has not priced in continued growth. But one quarter does not create a wonderful business, especially in trading. A 1000% profit growth number usually means the base was tiny. I also see the share price at ₹40.47, below the 52-week range of ₹45.31 to ₹103.95. That tells me the market is skeptical. Dividend yield is negligible, and debt/equity is not disclosed, so I cannot assess leverage properly. In a working-capital-intensive trading business, unknown debt levels worry me. I need durable profitability, better capital returns, and clear evidence that growth is not just a cyclical blip. Without a margin of safety, I will wait on the sidelines.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer